OXIDATIVE STRESS AND IT’S PHARMACOLOGICAL INTERVENTIONS IN CHRONIC DISEASES

Oxidative stress is a pathological condition resulting from an imbalance between the production of reactive oxygen species [ROS] and the antioxidant defense mechanisms of the body. Excessive generation of free radicals leads to cellular damage involving lipids, proteins, carbohydrates and nucleic acids, thereby contributing to the development and progression of several chronic diseases. Oxidative stress has been implicated in diabetes mellitus, cardiovascular diseases, neurodegenerative disorders, cancer, chronic kidney disease and inflammatory conditions. Pharmacological interventions targeting oxidative stress include natural antioxidants, synthetic antioxidant compounds, enzyme-based therapies and novel nanotechnology-based drug delivery systems. Natural compounds such as curcumin, resveratrol, quercetin and flavonoids exhibit significant antioxidant and anti-inflammatory properties. Synthetic agents including N-acetyl cysteine, edaravone and butylated hydroxytoluene have also demonstrated therapeutic potential in reducing oxidative damage. Recent advancements in nanomedicine and mitochondria-targeted antioxidants offer promising strategies for improving therapeutic efficacy and bioavailability. This review article discuss the mechanisms of oxidative stress, its role in chronic diseases and current pharmacological approaches aimed at minimizing oxidative injury and improving clinical outcomes.

• Free radicals in Biology and Medicine Halliwell B. Gutteridge JMC. 5th edition of University press; 2015. It explains oxidative stress mechanisms, ROS generation and disease pathology.
• Oxidative stress Sies H. Oxidative stress, a concept in redox biology and medicine 2015; Explains the concept and evolution of oxidative stress in biological systems.
• Jones DP. Redefining oxidative stress. Antioxidants and Redox signaling, 2006; Important paper discussion modern interpretation of oxidative stress and redox signaling.
• Liguori, et., al. Oxidative stress, aging and diseases. Clinical interventions in aging, 2018. Covers oxidative stress in aging and chronic disorders.
• Madamanchi NR, Vendrov A, Runge MS. Oxidative stress and vascular disease. Arteriosclerosis, Thrombosis ans vascular biology, 2005. Discusses ROS-mediated endothelial dysfunction and cardiovascular complications.
• Dhalla NS, et., al. role of oxidative stress in cardiovascular diseases. Journal of Hypertension, 2000. 
• Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circulations research. 2010; Highly cited article on ROS-mediated diabetic complications.
• Newsholme P, et., al Diabetes associated cell stress and dysfunction; role of mitochondrial and non-mitochondrial ROS production. Antioxidants and redox signaling. Types 2 diabetes.
• Barnham KJ, Masters CL, Bush AI. Neurodegenerative diseases and oxidative stress. Nature reviews drug discovery, 2004; Important review linking ROS to neurodegeneration.
• Uttara B, et., al. Oxidative stress and neurodegenerative diseases; a review of upstream and downstream antioxidant therapeutic options. Current Neuropharmacology, 2009.
• Reuter S, et., al. Oxidative stress, inflammation and cancer: how are they linked, Free radicals biology and medicine, 2010.
• Klauing JE. Oxidative stress and cancer. Current pharmaceutical design, 2018.
• Samuni Y, et., al. The chemistry and biological activites of N-acetylcystein. Biochimica et Biophysica Acta, 2013.
• Brigelius- Flohe R, Traber MG. Vitamin E: function and metabolism. FASEB journal, 1999.
• Carr A, Frei B. Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in Humans. American Journal of Clinical Nutrition, 1999.
• Hewlings SJ, Kalman DS. Curcumin: a review of its effects on human health. Foods, 2017.
• Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nature reviews durg discovery, 2006.
• Boots AW, Haenen GRMM, Bast A. Health effects of quercetin; from antioxidant to nutraceutical. European journal of pharmacology, 2008.
• Forman HJ, Zhang H. Targeting oxidative stress in disease: promise and limitations of antioxidant therapy. Nature reviews drug discovery, 2021. Discusses challenges and future prospects ofantioxidant pharmacology.
• Pizzino G, et., al. Oxidative stress: harms and benefits for human health. Oxidative medicine and cellular Longevity, 2017. Comprehensive reviews suitable for introduction and discussion sections.